Duska Therapeutics, Inc., based in Bala Cynwyd, Pennsylvania, develops new medicines to treat cardiovascular diseases by modulating the P2 receptor in the heart and lungs. In addition to ATPace™, (adenosine triphosphate injection) for the treatment and diagnosis of certain cardiac arrhythmias, Duska has drug development programs targeting chronic obstructive pulmonary disorders and cough, male infertility and mitigating the toxic effects of radiation exposure.

Contact Information

Two Bala Plaza
Suite 300
Bala Cynwyd, PA 19004

tel: 610-660-6690


Investor Relations

RedChip Companies, Inc.

tel: 1-800-REDCHIP
e-mail: info@redchip.com


Exchange: OTCBB
Industry: Drugs
Market Cap: $1.7M

The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.